市值 更改
AbbVie USD 364.22B 20.46B 2026-05
Acadia Pharmaceuticals USD 3.57B 221M 2026-05
Agios Pharmaceuticals USD 2.01B 423M 2026-03
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
Amgen USD 189.89B 13.64B 2026-03
Arrowhead Research USD 9.7B 920M 2026-05
Biogen USD 26.9B 1.09B 2026-03
BioMarin Pharmaceutical USD 10.18B 683M 2026-05
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Gilead Sciences USD 167.39B 5.6B 2026-05
Incyte USD 21.73B 3B 2026-05
Insmed USD 15.56B 19.73B 2026-05
Ionis Pharmaceuticals USD 12.46B 356M 2026-03
J&J USD 579.15B 78.91B 2026-03
Merck USD 297.1B 35.84B 2026-03
Moderna USD 20.15B 8.53B 2026-03
Neurocrine Biosciences USD 15.15B 1.9B 2026-05
Novartis USD 232.75B 75B 2026-05
Pfizer USD 147.4B 6.42B 2026-05
PTC Therapeutics USD 4.94B 698M 2026-05
Regeneron Pharmaceuticals USD 81.68B 560M 2026-03
Roche Holding CHF 266.34B 55.46B 2025-12
Sanofi EUR 100.27B 605.48M 2026-03
Sarepta Therapeutics USD 2.16B 123M 2026-05
Ultragenyx Pharmaceutical USD 2.06B 1000K 2026-05
United Therapeutics USD 28.08B 2.9B 2026-05
Vertex Pharmaceuticals USD 113.58B 1000K 2026-05